Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Apr
26
2014
Preexisting Management Plan Not a “Mitigation Measure” for Purposes of California Environmental Quality Act (CEQA) Exemption Sheppard, Mullin, Richter & Hampton LLP
Apr
12
2022
No April Fools: Starting April 1st, Cannabis Operators Face CEQA Compliance Requirements for State Licenses Sheppard, Mullin, Richter & Hampton LLP
Mar
29
2019
OH SNAP! Supreme Court to Take on Meaning of Key FOIA Exemption Sheppard, Mullin, Richter & Hampton LLP
Oct
24
2014
FTC Takes Action Against Unsubstantiated Caffeine-Infused Shapewear Weight-Loss Claims Sheppard, Mullin, Richter & Hampton LLP
Jul
5
2022
Recap of AHLA’s Annual Meeting Sheppard, Mullin, Richter & Hampton LLP
Mar
4
2015
Ascertainability Saps Plaintiffs’ Energy in Dietary Supplement Class Action Sheppard, Mullin, Richter & Hampton LLP
Jan
7
2020
FDA Year in Review: A Shifting Regulatory Landscape Sheppard, Mullin, Richter & Hampton LLP
Jun
16
2023
DOJ Continues to Discuss Updates to Compliance Program Guidance and Corporate Enforcement Policies Sheppard, Mullin, Richter & Hampton LLP
Mar
5
2020
Nota Bene Episode 71: Shifting Regulatory Landscapes at the FDA: Cannabis, Vaping and Intelligent Medical Devices with Allison Fulton [PODCAST] Sheppard, Mullin, Richter & Hampton LLP
Mar
10
2020
Prop 65 Warnings and Acrylamide in Food – Can I Still Have My Coffee and Drink it Too? Sheppard, Mullin, Richter & Hampton LLP
Mar
16
2020
FDA Grants COVID-19 Diagnostic Emergency Use Authorizations, And Other Recent FDA Actions With to Address COVID-19 Sheppard, Mullin, Richter & Hampton LLP
Apr
1
2020
Gifting Goods & Services to the U.S. Government in the Wake of the Coronavirus Outbreak Sheppard, Mullin, Richter & Hampton LLP
Oct
17
2023
Tele-Prescribing Flexibilities Extended Again in Second Temporary Rule Sheppard, Mullin, Richter & Hampton LLP
Nov
10
2023
From Good Reprint Practices to SIUU Communications: What Firms Need to Know Sheppard, Mullin, Richter & Hampton LLP
Jul
9
2020
COVID-19’s Continued Impacts on Cannabis Operators Sheppard, Mullin, Richter & Hampton LLP
Aug
17
2020
County Zoning Ordinance Cannot be Used to Justify Property Seizure Sheppard, Mullin, Richter & Hampton LLP
Sep
16
2020
Latest Update on FDA’s Software Pre-Cert Pilot Program Sheppard, Mullin, Richter & Hampton LLP
Dec
12
2011
FDA Announces Proposals for Biosimilars User Fees and Performance Review Goals Sheppard, Mullin, Richter & Hampton LLP
Apr
17
2013
Utility Pole Not A Point Source Under The Clean Water Act Sheppard, Mullin, Richter & Hampton LLP
Jul
6
2013
A Short-Lived Victory for Generic Drug Manufacturers? Sheppard, Mullin, Richter & Hampton LLP
Nov
6
2013
Supreme Court Grants Limited Review of Greenhouse Gas Emissions Regulations Sheppard, Mullin, Richter & Hampton LLP
Dec
13
2021
Debate Continues Around Scope of Practice Expansion for APPs Sheppard, Mullin, Richter & Hampton LLP
Apr
18
2022
Sow What Now?: Cal. Hispanic Chambers of Commerce et. al. v. Ross et. al., The U.S. Supreme Court, and California’s Proposition 12 Sheppard, Mullin, Richter & Hampton LLP
Apr
25
2019
Years in the Making: The Health Resources & Services Administration Launches a Website to Increase Pricing Transparency in the 340B Program Sheppard, Mullin, Richter & Hampton LLP
Jul
5
2022
CMS Adopts Major Changes to LTC Facility Surveyor Guidance Sheppard, Mullin, Richter & Hampton LLP
Jun
3
2019
The U.S. Trademark Office Opens The Door to Registering Certain Cannabis Trademarks Sheppard, Mullin, Richter & Hampton LLP
Jun
13
2023
Don’t Forget Deception: FTC and Biometrics Sheppard, Mullin, Richter & Hampton LLP
Jul
13
2023
The Ninth Circuit Declares that Ambiguity can be Cured with Back Label Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins